WeVote

Bill

Bill

HB 1076

INS CD-ALLERGENIC SUPPLEMENTS

104th Regular Session Introduced by Margaret Croke and 8 co-sponsors

Illinois bill requires dietary supplement makers to clearly label allergenic ingredients on packaging to protect consumers with allergies from potentially dangerous reactions.

House Floor Amendment No. 4 Referred to Rules Committee
0
WeVote Research Nonpartisan
Bill Summary · HB 1076

Legislative bill overview

HB 1076 requires manufacturers and distributors of dietary supplements containing allergenic ingredients to include clear labeling and disclosure of those ingredients on product packaging. The bill establishes standards for identifying major allergens (such as peanuts, tree nuts, shellfish, milk, eggs, soy, wheat, and fish) in supplement products, similar to existing food labeling requirements under federal law.

Why is this important

Dietary supplements are not regulated as strictly as food by the FDA, creating a gap where allergen information may be incomplete or unclear on labels. Consumers with severe allergies rely on accurate labeling to avoid potentially life-threatening reactions, making transparent allergen disclosure a public health safety issue. This bill attempts to close that regulatory gap at the state level.

Potential points of contention

  • Supplement industry burden: Manufacturers may argue compliance costs are high, particularly for smaller companies reformulating labels and testing products for undisclosed allergens
  • Regulatory scope: Questions about whether Illinois should regulate supplements differently than federal standards, and whether this creates inconsistent requirements across state lines
  • Definitional clarity: Disputes over what constitutes "allergenic supplements," cross-contamination thresholds, and which ingredients qualify as major allergens requiring disclosure

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.